BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34003214)

  • 1. Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes.
    Rahman MM; Herath D; Bladen JC; Atkar R; Pirzado MS; Harwood C; Philpott MP; Neill GW
    Carcinogenesis; 2021 Jul; 42(7):975-983. PubMed ID: 34003214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling.
    Li C; Chi S; He N; Zhang X; Guicherit O; Wagner R; Tyring S; Xie J
    Oncogene; 2004 Feb; 23(8):1608-17. PubMed ID: 14647422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
    Moutasim KA; Mellows T; Mellone M; Lopez MA; Tod J; Kiely PC; Sapienza K; Greco A; Neill GW; Violette S; Weinreb PH; Marshall JF; Ottensmeier CH; Sayan AE; Jenei V; Thomas GJ
    J Pathol; 2014 Jun; 233(2):196-208. PubMed ID: 24573955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.
    Wang J; Hollingshead J; El-Masry N; Horncastle D; Talbot I; Tomlinson I; Alison MR; El-Bahrawy M
    J Gastrointest Cancer; 2012 Sep; 43(3):444-55. PubMed ID: 21989899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of established tumour cells through narrow diameter micropores enriches for elevated Ras/Raf/MEK/ERK MAPK signalling and enhanced tumour growth.
    Rudzka DA; Mason S; Neilson M; McGarry L; Kalna G; Hedley A; Blyth K; Olson MF
    Small GTPases; 2021 Jul; 12(4):294-310. PubMed ID: 32569510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes.
    Almomani R; Khanfar M; Bodoor K; Al-Qarqaz F; Alqudah M; Hammouri H; Abu-Salah A; Haddad Y; Al Gargaz W; Mohaidat Z
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2851-2857. PubMed ID: 31554387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
    Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
    Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma.
    Neill GW; Ghali LR; Green JL; Ikram MS; Philpott MP; Quinn AG
    Cancer Res; 2003 Aug; 63(15):4692-7. PubMed ID: 12907651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway.
    Sun H; Hu Y; Gu Z; Owens RT; Chen YQ; Edwards IJ
    Carcinogenesis; 2011 Oct; 32(10):1518-24. PubMed ID: 21771724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
    Schnidar H; Eberl M; Klingler S; Mangelberger D; Kasper M; Hauser-Kronberger C; Regl G; Kroismayr R; Moriggl R; Sibilia M; Aberger F
    Cancer Res; 2009 Feb; 69(4):1284-92. PubMed ID: 19190345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
    Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
    Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
    Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTOR promotes basal cell carcinoma growth through atypical PKC.
    Chow RY; Levee TM; Kaur G; Cedeno DP; Doan LT; Atwood SX
    Exp Dermatol; 2021 Mar; 30(3):358-366. PubMed ID: 33617094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
    Brennan-Crispi DM; Hossain C; Sahu J; Brady M; Riobo NA; Mahoney MG
    Oncotarget; 2015 Apr; 6(11):8593-605. PubMed ID: 25871385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
    Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
    PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal differentiation in basal cell carcinoma: possible relationship to Hedgehog pathway activation?
    Gore SM; Kasper M; Williams T; Regl G; Aberger F; Cerio R; Neill GW; Philpott MP
    J Pathol; 2009 Sep; 219(1):61-8. PubMed ID: 19479712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes.
    Neill GW; Harrison WJ; Ikram MS; Williams TD; Bianchi LS; Nadendla SK; Green JL; Ghali L; Frischauf AM; O'Toole EA; Aberger F; Philpott MP
    Carcinogenesis; 2008 Apr; 29(4):738-46. PubMed ID: 18281251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of phosphorylated forms of ERK, MEK, PTEN and PI3K in mouse oral development.
    Cho KW; Cho SW; Lee JM; Lee MJ; Gang HS; Jung HS
    Gene Expr Patterns; 2008 Apr; 8(4):284-90. PubMed ID: 18203667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.